Fresh Off IPO, Quanterix Meets Its DestiNA
Mar 25, 2018 @ 18:47

Paramit Customer, Quanterix teams up with DestiNA to develop assays to detect liver toxicity in patients.

Sourced through Scoop.it from: www.mddionline.com

Leave a Reply